BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26066833)

  • 1. The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.
    Lorente L; Martín MM; Borreguero-León JM; Barrios Y; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A
    PLoS One; 2015; 10(6):e0129565. PubMed ID: 26066833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study.
    Madách K; Aladzsity I; Szilágyi A; Fust G; Gál J; Pénzes I; Prohászka Z
    Crit Care; 2010; 14(2):R79. PubMed ID: 20429897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent.
    García-Segarra G; Espinosa G; Tassies D; Oriola J; Aibar J; Bové A; Castro P; Reverter JC; Nicolás JM
    Intensive Care Med; 2007 Aug; 33(8):1354-62. PubMed ID: 17541549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.
    Hermans PW; Hibberd ML; Booy R; Daramola O; Hazelzet JA; de Groot R; Levin M
    Lancet; 1999 Aug; 354(9178):556-60. PubMed ID: 10470700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia.
    Sapru A; Hansen H; Ajayi T; Brown R; Garcia O; Zhuo H; Wiemels J; Matthay MA; Wiener-Kronish J
    Anesthesiology; 2009 May; 110(5):1086-91. PubMed ID: 19387177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4G/5G Polymorphism of the plasminogen activator inhibitor-1 gene is associated with multiple organ dysfunction in critically ill patients.
    Huq MA; Takeyama N; Harada M; Miki Y; Takeuchi A; Inoue S; Nakagawa T; Kanou H; Hirakawa A; Noguchi H
    Acta Haematol; 2012; 127(2):72-80. PubMed ID: 22134139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
    Geishofer G; Binder A; Müller M; Zöhrer B; Resch B; Müller W; Faber J; Finn A; Endler G; Mannhalter C; Zenz W;
    Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
    Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
    Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
    Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
    Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
    Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
    PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.
    Westendorp RG; Hottenga JJ; Slagboom PE
    Lancet; 1999 Aug; 354(9178):561-3. PubMed ID: 10470701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
    Burzotta F; Iacoviello L; Di Castelnuovo A; Zamparelli R; D'Orazio A; Amore C; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
    J Thromb Thrombolysis; 2003 Dec; 16(3):149-54. PubMed ID: 15087600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between PAI-1 polymorphisms and plasma PAI-1 level with sepsis in severely burned patients.
    Chi YF; Chai JK; Yu YM; Luo HM; Zhang QX; Feng R
    Genet Mol Res; 2015 Aug; 14(3):10081-6. PubMed ID: 26345945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.